A single center experience of Zilver PTX for femoro-popliteal lesions

Clinical trial data show overall favorable outcomes of paclitaxel-eluting stents for treatment of femoro-popliteal (FP) occlusive disease. However, external validity of trial results may be restricted to less complex FP lesions, and limited data on outcomes of paclitaxel-eluting stents in real world practice have been published.

Source: Cardiovascular Revascularization Medicine - August 1, 2016 Category: Cardiology Authors: Won Yu Kang, Umberto Campia, Romain J. Didier, Sarkis Kiramijyan, Edward Koifman, Smita I. Negi, Michael J. Lipinski, Nevin C. Baker, Ricardo O. Escarcega, Rebecca Torguson, Ron Waksman, Nelson L. Bernardo Source Type: research